Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center, China)

Establish a lung cancer diagnosis and treatment system with MDT as the core, carry out minimally invasive/robotic lobectomy, subsegmental resection and lymph node system dissection, and cooperate with SBRT, immune-combined targeted perioperative comprehensive treatment and precise positioning of tiny nodules.

Covers the entire process management of esophageal cancer, gastric cancer, and colorectal cancer. ERAS rapid recovery is parallel with endoscopic/robotic radical surgery. New adjuvant chemoradiotherapy, postoperative stratified follow-up, and minimal residual lesion (MRD) monitoring are carried out to guide medication.

Mature technologies such as complex hepatectomy and hepatic portal block, ALPPS, and portal vein embolization are combined with TACE/TARE, radiofrequency/microwave ablation, and systemic treatment to carry out precise radiotherapy for intrahepatic cholangiocarcinoma and molecular typing-guided treatment.

Standardized breast-conserving and axillary management and immediate reconstruction are carried out. Endocrine/chemotherapy regimens are guided based on multi-gene detection. Intraoperative image navigation and targeted intracavitary radiotherapy improve both cosmetic and oncological outcomes.

Staging surgery and comprehensive treatment platform for cervical/endometrial/ovarian tumors, large-scale screening for HPV-related precancerous lesions, and fertility-sparing conservative surgery and precise radiotherapy strategies.

Da Vinci robot-assisted radical prostatectomy, partial nephrectomy, and bladder reconstruction are routine. PSMA PET imaging is integrated to achieve staging and efficacy evaluation, and individualized pathways of radiotherapy + systemic treatment are promoted.

Laryngeal function preservation, parapharyngeal/skull base high-difficulty surgery are carried out, combined with stereotactic radiotherapy and strictly quality-controlled targeted/immunotherapy regimens, with emphasis on swallowing and speech rehabilitation.

Provides integrated solutions for neuro-navigation microsurgery, intraoperative MRI, and stereotactic radiotherapy (SRS/SRT) for glioma, meningioma, and brain metastases.

Focuses on bone and soft tissue sarcoma, GIST and other rare tumors, implements clear-margin wide resection, reconstruction and neoadjuvant/adjuvant therapy, and cooperates with molecular pathology consultation and clinical trials.

Covers NGS large panel, cfDNA/ctDNA dynamic monitoring, MSI/TMB detection and companion diagnostics, and builds a molecular oncology MDT and pharmacogenomics-guided medication.

Has the ability of image-guided adaptive radiotherapy (IGRT/ART), SBRT and stereotactic intracranial/body radiotherapy, and improves efficacy and safety with dosimetric optimization and online image evaluation.

Carries out liver cancer TACE/HAIC, transarterial radioembolization (TARE) referral and comprehensive management, percutaneous ablation and portal vein intervention, and combines systemic treatment to achieve transformation and bridging.